2m 2m 2m 2m 2m 2m 2m
PRAXIS PRECIS (PRAX)
NASDAQ
$301.44-$1.95 (-0.64%)
Price as of Jun 23, 2026 6:20 PM EDT- $8.5BMarket Cap
- 628.78%1-Year Change
- BiotechnologyIndustry
PRAXIS PRECIS (PRAX)
$301.44-$1.95 (-0.64%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 8.6M +249.53% | 2.4M N/A | N/A N/A | |
Cost of Revenue | 63.2M -8.62% | 69.2M N/A | N/A N/A | N/A N/A | |
Gross Profit | -63.2M +4.27% | -60.6M -2,577.28% | 2.4M N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -267.1M +75.26% | -152.4M +75.66% | -86.8M -44.04% | -155.0M +28.92% | |
Depreciation and Amortization Expense | 140,000 -60.89% | 358,000 -17.13% | 432,000 +3.10% | 419,000 +130.22% | |
Total Operating Expenses | 326.2M +56.29% | 208.7M +62.02% | 128.8M -40.08% | 215.0M +28.48% | |
Operating Profit | -326.2M +62.96% | -200.2M +58.39% | -126.4M -41.22% | -215.0M +28.48% | |
Interest Income | 0 -100.00% | 17.3M N/A | N/A N/A | 957,000 +253.14% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 -100.00% | 17.3M N/A | 0 -100.00% | 957,000 +253.14% | |
Total Nonoperating Income and Expense | 22.9M +32.19% | 17.3M +460.27% | 3.1M +223.51% | 957,000 +253.14% | |
Income before Taxes | -326.2M +62.96% | -200.2M +58.39% | -126.4M -41.22% | -215.0M +28.69% | |
Income Taxes | 471,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -303.3M +65.88% | -182.8M +48.30% | -123.3M -42.40% | -214.0M +28.11% | |
Net Income from Continuing Operations Applicable to Common | -303.3M +65.88% | -182.8M +48.30% | -123.3M -42.40% | -214.0M +28.11% | |
Basic EPS and Net Income | -13.48 +32.03% | -10.21 -45.37% | -18.69 +302.80% | -4.64 +17.77% | |
Diluted EPS and Net Income | -13.48 +32.03% | -10.21 -45.37% | -18.69 +302.80% | -4.64 +17.77% | |
Basic Weighted Average Shares | 22.5M +25.68% | 17.9M +171.55% | 6.6M -85.69% | 46.1M +8.58% | |
Diluted Weighted Average Shares | 22.5M +25.68% | 17.9M +171.55% | 6.6M -85.69% | 46.1M +8.58% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 357.3M +65.91% | 215.4M +164.91% | 81.3M +31.95% | 61.6M -55.58% | |
Short-Term Investments | 242.0M +36.57% | 177.2M +355.82% | 38.9M 0.00% | 38.9M -63.21% | |
Cash and Cash Equivalents and Short-Term Investments | 599.3M +52.67% | 392.6M +226.67% | 120.2M +19.59% | 100.5M -58.88% | |
Total Current Assets | 610.9M +51.08% | 404.4M +376.40% | 84.9M -23.42% | 110.8M -61.43% | |
Accumulated Depreciation | 1.5M +10.20% | 1.4M +35.62% | 1.0M +75.70% | 572,000 +273.86% | |
Property and Plant and Equipment and Net | 147,000 -36.09% | 230,000 -60.88% | 588,000 -39.44% | 971,000 -19.95% | |
Total Long-Term Assets | 0 -100.00% | 416,000 0.00% | 416,000 0.00% | 416,000 -11.86% | |
Total Assets | 937.9M +94.14% | 483.1M +449.31% | 87.9M -23.61% | 115.1M -60.67% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 59.8M +59.18% | 37.5M +138.43% | 15.7M -54.14% | 34.3M -10.64% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 110,000 -95.65% | 2.5M -45.91% | 4.7M +33.59% | |
Total Liabilities | 59.8M +58.71% | 37.7M +106.03% | 18.3M -53.16% | 39.0M -6.95% | |
Retained Earnings | -1.1B +36.24% | -836.7M +27.96% | -653.9M +23.23% | -530.6M +67.60% | |
Total Stockholders Equity | 878.1M +97.13% | 445.4M +539.38% | 69.7M -8.46% | 76.1M -69.66% | |
Total Shares Outstanding | 25.2M +29.72% | 19.4M +120.91% | 8.8M -82.20% | 49.4M +9.01% | |
Cash Flow | |||||
Cash from Operating Activities | -249.1M +89.04% | -131.8M +18.55% | -111.1M -39.94% | -185.0M +48.56% | |
Capital Expenditures | 56,000 N/A | 0 -100.00% | 50,000 -88.74% | 444,000 -57.71% | |
Cash from Investing Activities | -311.1M +25.21% | -248.5M -737.98% | 39.0M -59.80% | 96.9M +168.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 702.2M +36.52% | 514.3M +459.83% | 91.9M +777.89% | 10.5M -90.27% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | -708.75% N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -2,340.29% -54.68% | -5,164.41% N/A | N/A N/A | |
Return on Assets | -42.68% -33.34% | -64.03% -47.26% | -121.41% +15.69% | -104.95% +87.18% | |
Return on Equity | -45.83% -35.44% | -70.98% -58.03% | -169.13% +29.17% | -130.94% +110.94% | |
Revenue Growth | -100.00% -140.08% | 249.53% N/A | N/A N/A | N/A N/A | |
Current Ratio | 10.22 -5.09% | 10.77 +99.81% | 5.39 +67.00% | 3.23 -56.84% | |
Cash Ratio | 5.98 +4.23% | 5.74 +11.11% | 5.16 +187.75% | 1.79 -50.29% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow